Kestra Medical Technologies, Ltd.
KMTS
$20.70
$1.115.67%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.21% | -26.95% | 50.39% | -142.01% | -5.60% |
| Total Depreciation and Amortization | -16.43% | 17.01% | 10.46% | -2.75% | 1.02% |
| Total Amortization of Deferred Charges | 0.21% | -0.21% | 27.10% | 117.06% | -74.28% |
| Total Other Non-Cash Items | 3.14% | 258.70% | -89.75% | 1,532.25% | -24.29% |
| Change in Net Operating Assets | 197.61% | 111.89% | -72.86% | -861.11% | 86.23% |
| Cash from Operations | -0.13% | 30.19% | -10.87% | -31.68% | 0.33% |
| Capital Expenditure | -33.15% | 9.30% | -2.80% | -79.03% | 2.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,266.25% | 116.22% | -86.93% | 558.14% | -78.92% |
| Cash from Investing | -101.06% | 9.86% | -6.07% | -74.40% | -0.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -303.70% | 98.56% | 45.81% | -2,807.56% | 79.30% |
| Cash from Financing | 552,625.93% | 98.56% | -100.87% | 180,522.69% | 79.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 549.39% | 29.11% | -119.85% | 912.03% | 2.10% |